Thank you !

Access info about Acute Care EMR on your dashboard or bookmark under

(Your Products / Your Organization's Products)

We are currently researching Acute Care EMR.

Will you help us?

Take A Survey

Premium Reports
KLAS Contact

Contact KLAS

info@klasresearch.com

801.226.5120

KLAS - Contact KLAS
 Download Report Brief  Download Full Report    Zoom in charts

Preferences

   Bookmark

Related Series

Global EMR Trends
|
2015
International EPR Market 2012
|
2012

Related Segments

Related Products

Related Vendors

 End chart zoom
Global EMR Purchasing Decisions 2014 Global EMR Purchasing Decisions 2014
* A page refresh may be necessary to see the updated image

Global EMR Purchasing Decisions 2014
Usability and Integration Driving Mindshare

author - Jonathan Christensen
Author
Jonathan Christensen
 
September 18, 2014 | Read Time: 2  minutes

Current Time Inside Cache Tag Helper: 9/18/2021 11:40:31 PM and Model.reportId = 956

Healthcare systems outside the United States continue to make decisions on EMR technology. Which vendors are being selected and why? What criteria are most important? And what scares providers most about implementing such technology? KLAS spoke with potential buyers around the globe to find out.

Thank you !

Access info about Acute Care EMR on your dashboard or bookmark under

(Your Products / Your Organization's Products)

We are currently researching Acute Care EMR.

Will you help us?

Take A Survey

Healthcare Providers,
Want to see more reports?

Not a Provider, contact us for pricing details.

HtmlReportContent Current Time Inside Cache Tag Helper: 9/18/2021 11:40:31 PM and Model.reportId= 956 and Model.HtmlReportContent_LastWriteTimeUtcInTicks=637499622448767189

mindshare and likelihood to purchase

WORTH KNOWING:

SIX VENDORS HAVE GLOBAL MINDSHARE—CERNER AND EPIC LEAD.

Though Cerner† and Epic do not lead in global EMR market share,large and small provider organizations consider them far more often than they do any other vendors. Providers are most likely to lean toward Cerner as a probable choice, but Epic has significantly increased in mindshare despite a small global footprint—providers feel compelled to consider Epic based on their reputation in the market. The next most seriously considered vendors are MEDITECH, InterSystems, Allscripts, and Siemens. Reported market share for Siemens, InterSystems, and Agfa is not reflected in current mindshare.

FUNCTIONALITY VS. COSTCONUNDRUM.

Nearly 75% of providers listed usability as a top EMR criterion. Providers feel Epic is the clear leader in clinical usability and mention Cerner’s population health solutions. Perceived lower-cost solutions from Allscripts, CSC, InterSystems,and MEDITECH face an uphill battle; as providers weight their selections heavily toward usability and technology,higher-cost solutions Cerner and Epic benefit. Providers noted that no vendor clearly stands out in terms of mobility.

REGIONAL SOLUTIONS LOSINGGROUND IN THE UK.

Epic, InterSystems, Allscripts, and Cerner have seen the largest gains in UK mindshare since 2012. Alternatively,local products from System C and CSC have seen relatively little growth in mindshare as global competitors have increased exposure thanks to recent installs/contracts in the country. Cerner leads in overall mindshare in the UK, having capitalized on their increased performance and existing customer base.

† Data for this report was collected prior to Cerner’s announcement of their decision to acquire Siemens’ healthcare division.

vendors considered by regionwhos trending in the ukis cost excluding any vendorsimplementation concernstop purchasing criteria

 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.